Marvin Live to facilitate structure-based drug design
How to make better molecules faster is a key challenge in preclinical drug discovery. At Sprint Bioscience we use fragment-based techniques to quickly find high-quality chemical starting points for our small molecule drug discovery projects. Then, we use structure-based drug design to optimize the compounds towards clinical testing.
In this talk, we will illustrate how Marvin Live is used to streamline our collaborative workflow in the medicinal chemistry team – from a design idea to a target molecule ready to be synthesized in the lab.